FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

33723511000001104: Rasagiline 1mg tablets (Aristo Pharma GmbH) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Jan 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
102542801000001111 Rasagiline 1mg tablets (Aristo Pharma GmbH) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
103771401000001113 Rasagiline 1mg tablets (Aristo Pharma Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rasagiline 1mg tablets (Aristo Pharma GmbH) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Aristo Pharma GmbH) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Aristo Pharma GmbH) Is a Product containing precisely rasagiline 1 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Aristo Pharma GmbH) Has active ingredient Rasagiline false Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Aristo Pharma GmbH) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Aristo Pharma GmbH) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Aristo Pharma GmbH) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Aristo Pharma GmbH) Has specific active ingredient Rasagiline true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Aristo Pharma GmbH) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Aristo Pharma GmbH) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rasagiline true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Aristo Pharma GmbH) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Aristo Pharma GmbH) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (Aristo Pharma GmbH) Has basis of strength substance Rasagiline true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Rasagiline 1mg tablets (Aristo Pharma GmbH) 28 tablet 4 x 7 tablets Has AMP True Rasagiline 1mg tablets (Aristo Pharma GmbH) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start